Back
KEYENCE Corp. Vs. Novo Nordisk A/S Industry Stock Comparison
Sell
49
KYCCF
KEYENCE Corp.
Last Price:
$355.00
Seasonality Move:
3.13%
Sell
26
NVO
Novo Nordisk A/S
Last Price:
$50.17
Seasonality Move:
3.09%
Sell
49
KEYENCE Corp. (KYCCF)
is a Sell
Is KEYENCE Corp. a Buy, Sell or Hold?
-
The current KEYENCE Corp. [KYCCF] share price is $355.00. The Score for KYCCF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
KYCCF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $50.18. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KYCCF Stock Price Chart
What is KEYENCE Corp.'s stock price today?
-
The KEYENCE Corp. share price today is $355.00The current trend is relatively stagnant and KYCCF is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $50.18The current trend is relatively stagnant and NVO is experiencing slight selling pressure.
KYCCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.26 | Sell |
| Relative Strength Index (14 RSI): | 50.54 | Buy |
| Chaikin Money Flow: | -4907 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (339.4 - 357.12) | Buy |
| Bollinger Bands (100): | (357.03 - 395.91) | Sell |
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 54.9 | Buy |
| Chaikin Money Flow: | -4526726 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.65 - 49.41) | Buy |
| Bollinger Bands (100): | (47.99 - 58.53) | Sell |
KYCCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 349.09 | Buy |
| 20-day SMA: | 345.78 | Buy |
| 50-day SMA: | 370.51 | Sell |
| 200-day SMA: | 390.56 | Sell |
| 8-day EMA: | 350.37 | Buy |
| 20-day EMA: | 351.2 | Buy |
| 50-day EMA: | 362.72 | Sell |
| 200-day EMA: | 388.35 | Sell |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.26 | Buy |
| 20-day SMA: | 48.03 | Buy |
| 50-day SMA: | 51.08 | Sell |
| 200-day SMA: | 61.89 | Sell |
| 8-day EMA: | 48.72 | Buy |
| 20-day EMA: | 48.57 | Buy |
| 50-day EMA: | 50.6 | Sell |
| 200-day EMA: | 63.84 | Sell |
KEYENCE Corp. Earnings Growth & KYCCF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.54 per share, and a decrease next year of $0.15 per share.
KEYENCE Corp. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||